PPAR-γ agonists inhibit production of monocyte inflammatory cytokines (original) (raw)
References
Mangelsdorf, D. J. et al. The nuclear receptor superfamily: the second decade. Cell83, 835–839 (1995). ArticleCAS Google Scholar
Lemberger, T., Desvergne, B. & Wahli, W. Peroxisome proliferator-activated receptors: a nuclear receptor signaling pathway in lipid physiology. Annu. Rev. Cell Dev. Biol.12, 335–363 (1996). ArticleCAS Google Scholar
Chawla, A., Schwarz, E. J., Dimaculangan, D. D. & Lazar, M. A. Peroxisome proliferator-activated receptor (PPAR) gamma: adipose-predominant expression and induction early in adipocyte differentiation. Endocrinology135, 798–800 (1994). ArticleCAS Google Scholar
Tontonoz, P., Hu, E., Graves, R. A., Budavari, A. I. & Spiegelman, B. M. mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev.8, 1224–1234 (1994). ArticleCAS Google Scholar
Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPAR gamma 2, a lipid-activated transcription factor. Cell79, 1147–1156 (1994). ArticleCAS Google Scholar
Hu, E., Tontonoz, P. & Spiegelman, B. M. Transdifferentiation by myoblasts by the adipogenic transcription factor PPAR gamma and C/EBP alpha. Proc. Natl Acad. Sci. USA92, 9856–9860 (1995). ArticleADSCAS Google Scholar
Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem.270, 12953–12956 (1995). ArticleCAS Google Scholar
Kliewer, S. A. et al. Aprostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell83, 813–819 (1995). ArticleCAS Google Scholar
Forman, B. M. et al. 15-Deoxy-delta 12,14-porostaglandin J2 is a ligand for the adipocyte determination factor PPAR gamma. Cell83, 803–812 (1995). ArticleCAS Google Scholar
Lehmann, J. M., Lenhard, J. M., Oliver, B. B., Ringold, G. M. & Kliewer, S. A. Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem.272, 3406–3410 (1997). ArticleCAS Google Scholar
Hotamisligil, G. S., Shargill, N. S. & Spiegelman, B. M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science259, 87–91 (1993). ArticleADSCAS Google Scholar
Patton, J. S. et al. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc. Natl Acad. Sci. USA83, 8313–8317 (1986). ArticleADSCAS Google Scholar
Torti, F. M., Torti, S. V., Larrick, J. W. & Ringold, G. M. Modulation of adipocyte differentiation by tumor necrosis factor and transforming growth factor beta. J. Cell Biol.108, 1105–1113 (1989). ArticleCAS Google Scholar
Marshall, M. K., Doerrler, W., Feingold, K. R. & Grunfeld, C. Leukemia inhibitory factor induces changes in lipid metabolism in cultured adipocytes. Endocrinology135, 141–147 (1994). ArticleCAS Google Scholar
Berg, M., Fraker, D. L. & Alexander, H. R. Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes. Cytokine6, 425–432 (1994). ArticleCAS Google Scholar
Lang, C. H., Dobrescu, C. & Bagby, G. J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic gluose output. Endocrinology130, 43–52 (1992). ArticleCAS Google Scholar
Szalkowski, D., White-Carrington, S., Berger, J. & Zhang, B. Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-alpha on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells. Endocrinology136, 1474–1481 (1995). ArticleCAS Google Scholar
Braissant, O., Foufelle, F., Scotto, C., Dauca, M. & Wahli, W. Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat. Endocrinology137, 354–366 (1996). ArticleCAS Google Scholar
Greene, M. E. et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Express.4, 281–299 (1995). CAS Google Scholar
Devchand, P. R. et al. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature384, 39–43 (1996). ArticleADSCAS Google Scholar
Yu, K. et al. Differential activation of peroxisome proliferator-activated receptors by eicosanoids. J. Biol. Chem.270, 23975–23983 (1995). ArticleCAS Google Scholar
Meade, E. A., Smith, W. L. & DeWitt, D. L. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem.268, 6610–6614 (1993). CASPubMed Google Scholar
Lau, C. S., Morley, K. D. & Belch, J. J. Effects of fish oil supplementation on non-steroidal anti-inflammatory drug requirement in patients with mild rheumatoid arthritis—a double-blind placebo controlled study. Br. J. Rheumatol.32, 982–989 (1993). ArticleCAS Google Scholar
Feldmann, M., Brennan, F. M. & Maini, R. N. Role of cytokines in rheumatoid arthritis. Annu. Rev. Immunol.14, 397–440 (1996). ArticleCAS Google Scholar
Brennan, F. M. & Feldman, M. Cytokines in autoimmunity. Curr. Opin. Immunol.8, 872–877 (1996). ArticleCAS Google Scholar
Moreland, L. W. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N. Engl. J. Med.337, 141–147 (1997). ArticleCAS Google Scholar
McEvoy, G. K. (ed) AHFS 97 Drug Information (American Society of Health-Systems Pharmacists, Bethesda, MD, (1997)). Google Scholar
Firestein, G. S. & Zvaifler, N. J. Anticytokine therapy in rheumatoid arthritis. N. Engl. J. Med.337, 195–197 (1997). ArticleCAS Google Scholar